阻燃性性:一个案例系列的内巴克洛芬治疗:一个案例系列
Nicolas Medawar1, Ralph Abdallah2, Sandra Kobaiter Maarrawi3
1Faculty of medicine, Saint Joseph University, Beirut, Lebanon.
World neurosurgery
|May 11, 2024
概括
内巴克洛芬 (ITB) 疗法有效地控制了耐火性性,减少疼痛和改善移动性. 谨慎的,个性化的剂量非常重要,以最大限度地提高患者的益处,并尽量减少患者的副作用.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 康复医学 康复医学 康复医学
背景情况:
- 耐火性性 presents显著的临床管理挑战.
- 导管内巴克洛芬 (ITB) 疗法为耐火性性提供了一个有前途的治疗方法.
- 评估ITB治疗对治疗耐火性性症状的有效性至关重要.
研究的目的:
- 为了评估内巴克洛芬 (ITB) 治疗在耐火性性患者中的有效性.
- 确定与疼痛,移动性,频率和性缓解相关的关键结果.
主要方法:
- 对34名接受ITB治疗的耐火性性患者的回顾性图表审查.
- 数据收集包括患者的人口统计学,临床特征和给药剂量.
- 测量的主要结果是减少疼痛,改善移动性,减少频率和缓解性.
主要成果:
- 通过ITB治疗,疼痛和的频率显著降低.
- 观察到患者移动性和整体性的改善.
- 平均每日ITB剂量为245μg,但有效剂量是患者特异的,时间敏感的,副作用与错误的给药有关.
结论:
- 导管内巴克洛芬 (ITB) 疗法是耐火性的有效和安全治疗方法.
- 个性化剂量和密切监测对于优化ITB治疗结果和预防不良事件至关重要.
- 谨慎考虑风险和益处是最重要的 ITB 处方治疗耐火性性治疗时.
更多相关视频
相关概念视频
Drug Delivery: Parenteral Route
504
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
504
Centrally Acting Muscle Relaxants: Therapeutic Uses
669
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
669
Skeletal Muscle Relaxants: Therapeutic Uses
481
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
481
Local Anesthetics: Clinical Application as Spinal Anesthesia
620
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
620
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Spasmolytic Agents: Chemical Classification
879
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
879


